About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Found 257 record(s)
Req # A-2021-001384
The number of fatal adverse drug reactions reported to Health Canada between January 1, 2016 and Oct 30, 2021, in which non-stimulant Attention Deficit Hyperactivity Disorder (ADHD) medications are the primary suspect.Organization: Health Canada
December 2021
Req # A-2021-001386
The number of fatal adverse drug reactions reported to Health Canada between January 1, 2016 and Oct 30, 2021, in which antidepressants drugs are the primary suspect.Organization: Health Canada
December 2021
Req # A-2021-001387
The number of fatal adverse drug reactions reported to Health Canada between January 1, 2016 and Oct 30, 2021 in which stimulant drugs are the primary suspect.Organization: Health Canada
December 2021
Req # A-2021-001388
The number of fatal adverse drug reactions reported to Health Canada between January 1, 2016 and Oct 30, 2021, in which Benzodiazepine drugs are the primary suspect.Organization: Health Canada
December 2021
Req # A-2020-000394
Adverse Drug Reaction (ADR) for LEFLUNOMIDE. Report number: 000730796.Organization: Health Canada
December 2021
Req # A-2021-000038
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-117847-945.Organization: Health Canada
December 2021
Req # A-2021-000287
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-106381-329, Canada–Northwest Territories Bilateral Agreement for Pan-Canadian Virtual Care Priorities in Response to COVID-19.Organization: Health Canada
December 2021
Req # A-2021-000323
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-104716-552, Canada-Nova Scotia Bilateral Agreement for Pan-Canadian Virtual Care Priorities in Response to COVID-19.Organization: Health Canada
December 2021
Req # A-2021-000373
Adverse Drug Reaction (ADR). Report number: E2B_03829519.Organization: Health Canada
December 2021
Req # A-2021-000475
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-114293-165, Amendments to the Patented Medicines Regulations.Organization: Health Canada
December 2021